Previous Article | Next Article 
Journal of Bacteriology, September 2000, p. 5262-5266, Vol. 182, No. 18
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Lantibiotic Biosynthesis: Interactions between
Prelacticin 481 and Its Putative Modification Enzyme, LctM
Patricia
Uguen,
Jean-Paul
Le Pennec, and
Alain
Dufour*
Laboratoire de Biologie et Chimie
Moléculaires, EA 2594, Université de Bretagne Sud, Vannes,
France
Received 14 April 2000/Accepted 21 June 2000
 |
ABSTRACT |
Class AII and AIII lantibiotics and mersacidin are antibacterial
peptides containing unusual residues obtained by posttranslational modifications of prepeptides, presumably catalyzed by LanM. LctM, the
LanM for lacticin 481, is essential for the production of this class
AII lantibiotic. Using the yeast two-hybrid system, we showed direct
contact between the prelacticin 481 and LctM, supporting the proposed
LctM function. Sixteen domains are conserved between the 10 known LanM
proteins, whereas three additional domains were found only in class AII
LanM proteins and in MrsM, the LanM for mersacidin. All the truncated
LctM proteins that we tested presented impaired LctA-binding activity.
 |
TEXT |
Bacteriocins are ribosomally
synthesized peptides with antibacterial activity. Some bacteriocins
from gram-positive bacteria are termed lantibiotics because they
present the unique feature of containing unusual residues, leading to
intramolecular thioether bridges (20, 21). Lantibiotics are
produced as prepeptides encoded by structural genes. The unusual
residues are created in the prepeptide C-terminal part (propeptide) by
posttranslational modifications, whereas the prepeptide N-terminal
leader sequence is cleaved off (4, 20, 21). The unusual
residues are mainly the
,
-unsaturated amino acids dehydroalanine
(Dha) and dehydrobutyrine (Dhb) and the residues lanthionine (Lan) and
3-methyllanthionine (MeLan) harboring the thioether bonds. Dehydrations
of serine and threonine produce Dha and Dhb, respectively, which are
targets for nucleophilic addition of the SH group of cysteine residues, yielding Lan and MeLan. The most studied linear (type A)
lantibiotics belong to class AI, which includes in particular
nisin, subtilin, Pep5, and epidermin (4, 21).
Biosynthesis of these lantibiotics requires two modification enzymes,
LanB and LanC (Lan refers collectively to homologous proteins of
different lantibiotic systems). LanB would be involved in the
dehydration process and LanC in thioether bond formation, as shown in
the cases of nisin and Pep5, respectively (10, 14). It
has been shown in the cases of nisin and subtilin that LanB and
LanC form a lantibiotic synthetase complex also including the
transmembrane ATP-binding cassette (ABC) transporter LanT and
that both LanB and LanC interact directly with the lantibiotic prepeptide (11, 22). In comparison, information related to the biosynthesis of other type A lantibiotics is scarce. Lacticin 481 contains 1 Dhb, 1 MeLan, and 2 Lan residues responsible for a rather
globular C terminus, whereas the N-terminal part is unbridged (16,
20, 25). This lantibiotic is representative of several highly
similar bacteriocins (streptococcin A-FF22, mutacin II, salivaricin A,
variacin, streptococcin A-M49, and butyrivibriocin OR79A) that have
been regrouped so far into class AII (9, 13). The gene
clusters for lacticin 481, mutacin II, and streptococcin A-FF22 have
been reported (3, 13, 18). They are similarly organized,
each including the structural gene lanA followed by the
genes lanMTFEG (Fig. 1) but no
counterpart of lanB or lanC. The six genes of the
lacticin 481 operon are sufficient to confer high levels of lantibiotic
production to a Lactococcus strain (18). LanT and
LanFEG form two ABC transporters, the first one responsible for both
the cleavage of the leader peptide and the export of the mature
bacteriocin (8), and the second one protecting the strain
from its own lantibiotic (18). As LanM proteins show limited
similarities with conserved segments of LanC proteins (12,
23), it is assumed that they catalyze the formation of the
unusual residues. According to this hypothesis, LanM should be
essential for lantibiotic biosynthesis. This was partially verified in
the lacticin 481 case, since introduction into Lactococcus lactis IL1403 of lctA and lctM only
(lct refers to the lacticin 481 operon genes) resulted in
low bacteriocin activity, which was abolished by deleting the 3' end of
lctM (17). The butyrivibriocin OR79A gene
cluster has been reported (9) and includes genes similar to lanFEGAM, the lanM (which we name here
bviM instead of ORF6) being only partially sequenced. LanM
proteins are also encoded by the gene clusters for class AIII
lantibiotics, the third subgroup of linear lantibiotics which
tentatively includes lactocin S (24) and two-component
lantibiotics, the full activity of which requires the synergistic
action of two peptides, such as cytolysin, staphylococcin C55, and
lacticin 3147 (7, 15, 19). LanM homologues are essential for
the production of cytolysin and lactocin S (7, 24). Finally,
a LanM counterpart, MrsM, is encoded by the gene cluster for mersacidin
(1), which is a lantibiotic more closely related to type B
(globular peptides) than to type A lantibiotics (2). In the
present study, we showed that LctM is essential for lacticin 481 biosynthesis even when the five other lct genes are
expressed, and we used the yeast two-hybrid system to detect and study
direct interactions between LctM and the lacticin 481 prepeptide LctA.
We also compared the sequences of all known LanM proteins, identifying
19 conserved regions, 3 of which are found only in class AII LanM
proteins and in MrsM. Finally, we tested the LctA-binding activity of
truncated variants of LctM.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Organization of the lacticin 481 operon. The number of
codons in each gene is given below its name. P and T indicate the
promoter region and a terminator, respectively. pEB200 and pEB134 are
fusions of pIL253 and pBluescript containing the inserts shown by the
continuous lines. The dashed line corresponds to the deleted
NdeI fragment.
|
|
LctM is essential for lacticin 481 production.
We previously
showed that lctM was necessary to produce lacticin 481 when
it was the only gene expressed with lctA (17). To
examine whether this is still the case when the remainder of the
lacticin 481 operon in addition to lctA is expressed, an
in-frame deletion of 77% of lctM was created by removing
the 2.1-kb NdeI fragment (Fig. 1) from pEF94, which contains
lctAMTFEG in pBluescript KS (18). To allow
replication and selection in L. lactis, the resulting
plasmid was fused to the vector pIL253, creating pEB134. In L. lactis IL1403, pEB134 failed to induce detectable bacteriocin activity, indicating that culture supernatants contained less than 10 arbitrary units (AU) of lacticin 481 · ml
1.
In contrast, a plasmid carrying the complete operon (Fig. 1, pEB200)
led to the accumulation of up to 5,000 AU of lacticin 481 · ml
1 in culture supernatants. The lctATFEG
genes are thus not sufficient to produce lacticin 481. This could not
result from an impaired expression of the lct genes, since
pEB134 provided L. lactis IL1403 with the same high level of
protection against lacticin 481 as pEB200 (whereas L. lactis
IL1403 containing the vector only was inhibited by 10 AU of lacticin
481 · ml
1 [18], 1,280 AU · ml
1 was required when the strain harbored pEB134 or
pEB200). These results show that lacticin 481 biosynthesis absolutely
requires LctM.
A LctA-LctM interaction is detected by the yeast two-hybrid
system.
If the assumption that LctM modifies the propeptide part
of LctA is correct, one would expect that the two molecules would make
direct physical contact. We examined this hypothesis with the yeast
two-hybrid system, which detects even transient protein interactions
such as enzyme-substrate interactions (6) and was used to
show direct contacts between prelantibiotics and LanB or LanC (11,
22). lctA and lctM were amplified by PCR
and cloned into pGBT9 and pGAD424 (Matchmaker GAL4 two-hybrid system; Clontech Laboratories, Palo Alto, Calif.) as indicated in Table 1, in order to produce chimeric proteins
including LctA or LctM fused to one of the two separate domains of the
yeast transcriptional activator GAL4: the DNA binding domain (BD) and
the transcriptional activation domain (AD). Within the yeast strain
Saccharomyces cerevisiae SFY526, an interaction between the
proteins fused to the GAL4 domains leads to transcriptional activation
of the reporter gene lacZ. This activation was examined by
using the
-galactosidase colony lift filter assay (yeast protocols
handbook, Clontech) on at least 15 yeast colonies resulting from the
cotransformation of SFY526 by one pGBT9 and one pGAD424 derivative. The
results are shown in Table 2. High
-galactosidase activity was detected in yeasts producing
BD::LctA (pHB246) and AD::LctM (pHA689 or pHA888).
As yeasts producing BD::LctA and AD or AD::LctM and
BD did not contain detectable levels of
-galactosidase, this result indicated an interaction between LctA and LctM. The reciprocal fusions AD::LctA (pHA409) and BD::LctM (pHB685 or
pHB887) failed to activate the reporter gene. However, such
interactions, which could not be confirmed by the reciprocal
fusions, have been reported (6, 26), without
invalidating the positive result. When we quantified the enzyme
activity from liquid cultures using
o-nitrophenyl-
-D-galactopyranoside (ONPG) as the substrate (yeast protocols handbook, Clontech), the
activity induced by the BD::LctA-AD::LctM
interaction was 9,400-fold higher than the background activity (e.g.,
BD::LctA-AD) (Table 2). This confirms the interaction between
LctA and LctM, which supports the notion that LctM is the enzyme for
the posttranslational modifications of prelacticin 481.
LanM proteins display conserved domains.
The sequences of
LctM, LasM (lactocin S), and CylM (cytolysin) were compared in previous
studies, showing that the six (24) or seven (23)
domains conserved among LanC proteins are also found in the LanM
C-terminal parts and identifying one (23) to four
(24) domains shared by their N-terminal parts. Since these
works, the sequences of seven other LanM proteins have been reported:
MutM (mutacin II), ScnM (streptococcin A-FF22), LtnM1 and LtnM2
(lacticin 3147), SacM1 (staphylococcin C55), BviM
(butyrivibriocin OR79A), and MrsM (mersacidin) (1, 5, 9, 13, 15,
27). We compared these sequences and observed that LctM
shares 26 to 32% identity with the other class AII LanM proteins
(MutM, ScnM, and BviM), 19 to 23% identity with class AIII LanM
proteins (SacM1, LtnM1, LtnM2, LasM, and CylM), and 25% identity
with MrsM. The conserved amino acids are clustered in distinct domains,
and we propose to distinguish 19 of them (Fig.
2 and 3). In the C-terminal regions,
domains C1 to C4 and C6 to C8 are conserved within all LanM proteins
and correspond to the seven LanC domains (Fig. 2). Furthermore, the H,
WC, and CH residues of domains C4, C6, and C7, which could be involved
in the enzymatic activity of LanC, disulfide bond formation, or
metal-ion binding (12, 23), are common to all LanM proteins.
The glycines of the seven domains could be important for the structure
or activity of LanC (12, 23), and are also well conserved
within LanM proteins. Domain C5 is common to the four class AII LanM
proteins but is absent from the class AIII LanM proteins and from LanC.
The N-terminal two-thirds of LctM did not show any significant
similarity with proteins other than LanM. Within these regions, we
propose 11 conserved domains designated N1 to N11 (Fig. 2 and 3).
Whereas domains N2 to N5 and N7 to N11 are shared by all LanM proteins, domains N1 and N6 are highly conserved in the four class AII LanM proteins but not in the class AIII LanM proteins. Class AII prepeptides are very closely related in terms of primary sequence and the disposition and identity of the modified residues (9). It is thus not surprising that their putative modification enzymes are more
closely related to each other than to class AIII LanM proteins, which
process more distantly related prebacteriocins. The conservation or
lack of conservation of LanM domains N1, N6, and C5 confirms the
proposed classification of lacticin 481, mutacin II, streptococcin A-FF22, and butyrivibriocin OR79A, on the one hand, and of lacticin 3147, staphylococcin C55, cytolysin, and lactocin S, on the other, into
two different subgroups. This feature could thus be considered a new
criterion of lantibiotic classification. It is not, however, sufficient
and should not be considered independently of the characteristics of
the lantibiotic and its prepeptide, as shown by the case of mersacidin.
Although the latter was not included in class AII or AIII, due to the
differences between premersacidin and type A prepeptides
(2), its LanM (MrsM) shares all the LanM conserved domains, including the three class AII-specific domains (Fig. 2).
The only obvious divergent feature of MrsM compared to the class AII
LanM proteins is a longer sequence preceding domain N1 (165 versus 41 to 48 residues). The sequences of other LanM proteins encoded by
operons for mersacidin-related lantibiotics will be required in order
to draw more-accurate conclusions. Another interpretation would be that
mersacidin and class AII lantibiotics are more closely
related than previously thought. A similar conclusion was drawn
very recently by Altena et al. (1) on the basis of overall
gene cluster organization and new comparisons of prepeptide leader
sequences. In their most recent review (20), Sahl and Bierbaum wondered whether the grouping of lacticin 481-related lantibiotics (class AII) into type A (linear) lantibiotics is appropriate, because of their partially globular structure. If one
could imagine defining a new lantibiotic type for class AII lantibiotics, type C, intermediate between types A and B (globular), this new type could also include mersacidin and the related
actagardin, which have been classified as type B lantibiotics without
sharing all their characteristics (2). The question of
whether the common features of class AII bacteriocins and mersacidin
are sufficient to regroup them in a single type despite their
differences remains open. For class AIII lantibiotics, the information
related to their structures is too scarce to question their
relationship with type A lantibiotics.

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 2.
Conserved domains within LanM and LanC. The domains are
designated N1 to N11 and C1 to C8. LanM proteins are divided into two
subgroups, one including the four class AII LanM proteins (LctM, MutM,
ScnM, and BviM) and MrsM and the other composed of the five class AIII
LanM proteins (SacM1, LtnM1, LtnM2, LasM, and CylM). Residues identical
either in LanM proteins from the first subgroup (domains N1, N6, and
C5) or in all LanM proteins (other domains) are on a solid background,
whereas residues similar or identical in at least 60% of the proteins
are on a dark shaded background. A light shaded background indicates
residues from LanM proteins of the second subgroup that are identical
or similar to residues conserved within domains N1 and N6. The numbers
of amino acids before, between, and after the sequences represented are
given. The total numbers of residues are given in parentheses at the
ends of the sequences, followed by the database accession numbers. The
consensus sequence for the conserved domains of LanC is given, with x
indicating undefined positions. Residues of the LanC consensus that are
conserved within LanM are on the corresponding background. The
consensus is drawn from the work of Siezen et al. (23) and
our own comparison including NisC, SpaC, EpiC, PepC (database accession
numbers as in reference 23), MutC, EciC, and Scf1.12
(accession numbers AF154675, Y14023, and AL117322, respectively). A
residue was included in the consensus if it or a similar amino acid was
found in at least 70% of LanC proteins. Dots and stars indicate
residues similar or identical, respectively, in the seven LanC
proteins. The smallest and largest numbers of amino acids preceding and
following each LanC sequence are given. The total numbers of residues
of the smallest and largest LanC proteins are given in parentheses at
the end of the sequence.
|
|
Truncated LctM showed impaired interactions with LctA.
In
order to examine if the interaction detected between LctA and LctM
could be assigned to a particular region of LctM, we constructed
several derivatives of pHA888, each containing a deletion (in frame
when internal to lctM) allowing the expression of a truncated version of LctM fused to the GAL4 activation domain (Fig. 3).
None of these fusions induced
-galactosidase activities higher than
0.01 ± 0.01 Miller units when coexpressed with the GAL4 BD alone.
The
-galactosidase activities assayed from yeast cells coexpressing
one of these proteins and BD::LctA are shown in Fig.
3. We first looked for the interactions
between LctA and either the N- or the C-terminal region of LctM.
Whereas the C-terminal region (M
17-569) failed to interact
with LctA, the N-terminal region (M
570-922) retained a significant
LctA-binding ability, inducing a
-galactosidase activity 100-fold
higher than the background. This activity was, however, about 100-fold
lower than that obtained with the complete LctM, suggesting that
the C-terminal region somehow participates in the LctA-binding
activity. We further subdivided the N-terminal region in two parts
comprising domains N1 to N5 (up to residue 306) and domains N6 (without
its first 3 residues, FGG) to N11 (residues 307 to 569). The
deletion of the second part reduced the
-galactosidase
activity either 14-fold (M
307-922 versus M
570-922) or 470-fold
(M
307-569 versus LctM). The absence of residues 17 to 306 (M13017-306) abolished the interaction with LctA, but these residues
by themselves (M
307-922) were not sufficient to account for the
affinity of LctM for LctA. We thus could not assign the LctA-binding
activity of LctM to a particular region of the latter. It is likely
that this activity requires several residues scattered within LctM.
Since LctM is a much larger protein than LctA (922 versus 51 amino
acids), we could speculate that the spatial distribution of these
residues in the native LctM forms a LctA-binding pocket. Truncating any
portion of the protein could therefore alter such a LctA-binding site
not only by removing one or several residues involved in the direct
contact with LctA but also by changing their appropriate spacing or by preventing correct folding of the protein. To gather data on the involved residues, one would need to analyze the LctA-binding activity
of LctM harboring point mutations. The residues that we
identified here as identical either in all LanM proteins (18 and
13 residues in the N- and C-terminal domains, respectively) or in
domains N1, N6, and C5 of class AII LanM proteins and MrsM (14 and 2 residues in the N- and C-terminal domains, respectively) would probably
be interesting mutagenesis targets.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
LctM and truncated derivatives fused to the GAL4
activator domain. pHA888 is pGAD424 containing the insert (full-length
lctM) represented by the heavy top line. The following
restriction sites are indicated: B, BamHI; Bc,
BclI; Bg, BglII; E, EcoRI; P,
PstI. The other plasmids result from deletions in pHA888
created at the indicated restriction sites, with the deleted fragments
represented by dashed lines. The encoded proteins are represented by
boxes in which the domains conserved between LanM and LanC, among LanM
proteins, and between class AII LanM proteins and MrsM are indicated by
light shading, dark shading, and black, respectively. The domains are
numbered according to Fig. 2. The numbers next to the boxes indicate
their last or first residues. The -galactosidase activities given
are means ± standard errors of duplicate or triplicate assays
from at least three distinct liquid cultures of yeast cells
coexpressing the corresponding AD::LctM fusion and
BD::LctA (pHB246).
|
|
 |
ACKNOWLEDGMENTS |
P.U. was the recipient of a doctoral fellowship from the
Région Bretagne.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: LBCM, UBS,
Avenue de Tohannic, 56000 Vannes, France. Phone: (33) 2-97-68-31-93. Fax: (33) 2-97-68-16-39. E-mail: alain.dufour{at}univ-ubs.fr.
Present address: Chemical Pathology Unit, Sir William Dunn School
of Pathology, Oxford OX1 3RE, United Kingdom.
 |
REFERENCES |
| 1.
|
Altena, K.,
A. Guder,
C. Cramer, and G. Bierbaum.
2000.
Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster.
Appl. Environ. Microbiol.
66:2565-2571[Abstract/Free Full Text].
|
| 2.
|
Bierbaum, G.,
H. Brötz,
K.-P. Koller, and H.-G. Sahl.
1995.
Cloning, sequencing and production of the lantibiotic mersacidin.
FEMS Microbiol. Lett.
127:121-126[CrossRef][Medline].
|
| 3.
|
Chen, P.,
F. Qi,
J. Novak, and P. W. Caufield.
1999.
The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc.
Appl. Environ. Microbiol.
65:1356-1360[Abstract/Free Full Text].
|
| 4.
|
de Vos, W. M.,
O. P. Kuipers,
J. R. van der Meer, and R. J. Siezen.
1995.
Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by Gram-positive bacteria.
Mol. Microbiol.
17:427-437[Medline].
|
| 5.
|
Dougherty, B. A.,
C. Hill,
J. F. Weidman,
D. R. Richardson,
J. C. Venter, and R. P. Ross.
1998.
Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid pMRC01 from Lactococcus lactis DPC3147.
Mol. Microbiol.
29:1029-1038[CrossRef][Medline].
|
| 6.
|
Fields, S., and R. Sternglanz.
1994.
The two-hybrid system: an assay for protein-protein interactions.
Trends Genet.
10:286-291[CrossRef][Medline].
|
| 7.
|
Gilmore, M. S.,
R. A. Segarra,
M. C. Booth,
C. P. Bogie,
L. R. Hall, and D. B. Clewell.
1994.
Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants.
J. Bacteriol.
176:7335-7344[Abstract/Free Full Text].
|
| 8.
|
Håvarstein, L. S.,
D. B. Diep, and I. F. Nes.
1995.
A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export.
Mol. Microbiol.
16:229-240[Medline].
|
| 9.
|
Kalmokoff, M. L.,
D. Lu,
M. F. Whitford, and R. M. Teather.
1999.
Evidence for production of a new lantibiotic (butyrivibriocin OR79A) by the ruminal anaerobe Butyrivibrio fibrisolvens OR79: characterization of the structural gene encoding butyrivibriocin OR79A.
Appl. Environ. Microbiol.
65:2128-2135[Abstract/Free Full Text].
|
| 10.
|
Karakas Sen, A.,
A. Narbad,
N. Horn,
H. M. Dodd,
A. J. Parr,
I. Colquhoun, and M. J. Gasson.
1999.
Post-translational modification of nisin. The involvement of NisB in the dehydration process.
Eur. J. Biochem.
261:524-532[Medline].
|
| 11.
|
Kiesau, P.,
U. Eikmanns,
Z. Gutowski-Eckel,
S. Weber,
M. Hammelmann, and K.-D. Entian.
1997.
Evidence for a multimeric subtilin synthetase complex.
J. Bacteriol.
179:1475-1481[Abstract/Free Full Text].
|
| 12.
|
Kupke, T., and F. Götz.
1996.
Expression, purification, and characterization of EpiC, an enzyme involved in the biosynthesis of the lantibiotic epidermin, and sequence analysis of Staphylococcus epidermidis epiC mutants.
J. Bacteriol.
178:1335-1340[Abstract/Free Full Text].
|
| 13.
|
McLaughlin, R. E.,
J. J. Ferretti, and W. L. Hynes.
1999.
Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes.
FEMS Microbiol. Lett.
175:171-177[CrossRef][Medline].
|
| 14.
|
Meyer, C.,
G. Bierbaum,
C. Heidrich,
M. Reis,
J. Süling,
M. I. Iglesias-Wind,
C. Kempter,
E. Molitor, and H.-G. Sahl.
1995.
Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation.
Eur. J. Biochem.
232:478-489[Medline].
|
| 15.
|
Navaratna, M. A. D. B.,
H.-G. Sahl, and J. R. Tagg.
1999.
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene.
Infect. Immun.
67:4268-4271[Abstract/Free Full Text].
|
| 16.
|
Piard, J.-C.,
O. P. Kuipers,
H. S. Rollema,
M. J. Desmazeaud, and W. M. de Vos.
1993.
Structure, organization, and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis.
J. Biol. Chem.
268:16361-16368[Abstract/Free Full Text].
|
| 17.
|
Rincé, A.,
A. Dufour,
S. Le Pogam,
D. Thuault,
C. M. Bourgeois, and J.-P. Le Pennec.
1994.
Cloning, expression, and nucleotide sequence of genes involved in production of lactococcin DR, a bacteriocin from Lactococcus lactis subsp. lactis.
Appl. Environ. Microbiol.
60:1652-1657[Abstract/Free Full Text].
|
| 18.
|
Rincé, A.,
A. Dufour,
P. Uguen,
J.-P. Le Pennec, and D. Haras.
1997.
Characterization of the lacticin 481 operon: the Lactococcus lactis genes lctF, lctE, and lctG encode a putative ABC transporter involved in bacteriocin immunity.
Appl. Environ. Microbiol.
63:4252-4260[Abstract].
|
| 19.
|
Ryan, M. P.,
R. W. Jack,
M. Josten,
H.-G. Sahl,
G. Jung,
R. P. Ross, and C. Hill.
1999.
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.
J. Biol. Chem.
274:37544-37550[Abstract/Free Full Text].
|
| 20.
|
Sahl, H.-G., and G. Bierbaum.
1998.
Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria.
Annu. Rev. Microbiol.
52:41-79[CrossRef][Medline].
|
| 21.
|
Sahl, H.-G.,
R. W. Jack, and G. Bierbaum.
1995.
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
Eur. J. Biochem.
230:827-853[Medline].
|
| 22.
|
Siegers, K.,
S. Heinzmann, and K.-D. Entian.
1996.
Biosynthesis of lantibiotic nisin. Posttranslational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthetase complex.
J. Biol. Chem.
271:12294-12301[Abstract/Free Full Text].
|
| 23.
|
Siezen, R. J.,
O. P. Kuipers, and W. M. de Vos.
1996.
Comparison of lantibiotic gene clusters and encoded proteins.
Antonie Leeuwenhoek
69:171-184[CrossRef][Medline].
|
| 24.
|
Skaugen, M.,
C. I. Abildgaard, and I. F. Nes.
1997.
Organization and expression of a gene cluster involved in the biosynthesis of the lantibiotic lactocin S.
Mol. Gen. Genet.
253:674-686[CrossRef][Medline].
|
| 25.
|
van den Hooven, H. W.,
F. M. Lagerwerf,
W. Heerma,
J. Haverkamp,
J.-C. Piard,
C. W. Hilbers,
R. J. Siezen,
O. P. Kuipers, and H. S. Rollema.
1996.
The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges.
FEBS Lett.
391:317-322[CrossRef][Medline].
|
| 26.
|
Voelker, U.,
A. Voelker, and W. G. Haldenwang.
1996.
The yeast two-hybrid system detects interactions between Bacillus subtilis B regulators.
J. Bacteriol.
178:7020-7023[Abstract/Free Full Text].
|
| 27.
|
Woodruff, W. A.,
J. Novak, and P. W. Caufield.
1998.
Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans.
Gene
206:37-43[CrossRef][Medline].
|
Journal of Bacteriology, September 2000, p. 5262-5266, Vol. 182, No. 18
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Uguen, P., Hindre, T., Didelot, S., Marty, C., Haras, D., Le Pennec, J.-P., Vallee-Rehel, K., Dufour, A.
(2005). Maturation by LctT Is Required for Biosynthesis of Full-Length Lantibiotic Lacticin 481. Appl. Environ. Microbiol.
71: 562-565
[Abstract]
[Full Text]
-
Gomez, A., Ladire, M., Marcille, F., Nardi, M., Fons, M.
(2002). Characterization of ISRgn1, a Novel Insertion Sequence of the IS3 Family Isolated from a Bacteriocin-Negative Mutant of Ruminococcus gnavus E1. Appl. Environ. Microbiol.
68: 4136-4139
[Abstract]
[Full Text]
-
Gomez, A., Ladire, M., Marcille, F., Fons, M.
(2002). Trypsin Mediates Growth Phase-Dependent Transcriptional Regulation of Genes Involved in Biosynthesis of Ruminococcin A, a Lantibiotic Produced by a Ruminococcus gnavus Strain from a Human Intestinal Microbiota. J. Bacteriol.
184: 18-28
[Abstract]
[Full Text]